Selective T Cell Costimulation Modulator [EPC]

108247 reported adverse events

Drugs of this class: ABATACEPT

These side effects are most commonly reported by patients taking drugs of the Selective T Cell Costimulation Modulator [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 35238
1 RHEUMATOID ARTHRITIS 19326
2 PAIN 16891
3 ARTHRALGIA 14327
4 JOINT SWELLING 13680
5 CONTRAINDICATED PRODUCT ADMINISTERED 12036
6 FATIGUE 11342
7 DRUG INTOLERANCE 11061
8 RASH 10024
9 ARTHROPATHY 9286
See all common reactions for Selective T Cell Costimulation Modulator [EPC]

Drugs of the Selective T Cell Costimulation Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 279 0.9238
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3304 0.8611
2 SWOLLEN JOINT COUNT INCREASED 886 0.8462
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 171 0.7953
4 RED BLOOD CELL SEDIMENTATION RATE 205 0.7915
5 PEMPHIGUS 6259 0.7881
6 RHEUMATOID FACTOR NEGATIVE 134 0.7836
7 RHEUMATOID FACTOR POSITIVE 2712 0.7807
8 RHEUMATIC FEVER 1097 0.7655
9 LUPUS VULGARIS 127 0.7341
See all enriched reactions for Selective T Cell Costimulation Modulator [EPC]